CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- 8-K Event Executive or director change
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement · Agreement ended
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-K Event Results of operations · Exit or restructuring costs · Executive or director change
- 8-K Event Delisting notice · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Material agreement · Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Results of operations
Page 3 of 5 · 96 filings